US imposes 100% tariff on patented drug imports unless co. signs drug pricing deal or agrees to make product in the US, according to White House fact sheet
- Drugmakers face 100% tariff unless they cut prices or produce drugs in the US.
- Pharmaceutical tariff reduced to 15% on Europe, Japan, South Korea, and Switzerland due to trade deals
- Tariff can be reduced to 20% if companies move manufacturing to US.
- Has made 17 pharma deals; signed 13 and negotiating remaining four.
- Large pharma companies have 120 days to make announcements to avoid 100% tariff
- Smaller pharmaceutical companies have 180 days to avoid higher tariff
- Companies that move manufacturing to the US and sign most-favored-nation drug pricing deals with US HHS are exempt from pharmaceutical tariffs
02 Apr 2026 - 20:27- ForexImportant- Source: White House
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts